Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radiolabelled Nectin-4 Targeted LMW Probe PET/CT in Patients With Lung Lesions

NCT06648317 is registered in ClinicalTrials.gov with Peking University Cancer Hospital & Institute as lead sponsor.

NCT NCT06648317
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06648317 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radiolabelled Nectin-4 Targeted LMW Probe PET/CT in Patients With Lung Lesions
Lead sponsor
Peking University Cancer Hospital & Institute
Phase
Observational
Overall status
Recruiting
Start date
November 21, 2024
Completion date
December 1, 2025
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, non-small cell, lung infection